Unresectable Gastric Adenocarcinoma
7 clinical trials · Condition
◉ Watch Unresectable Gastric Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma (NCT05041153) | M.D. Anderson Cancer Center | 2022-02-14 |
| Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer (NCT03641313) | National Cancer Institute (NCI) | 2020-11-16 |
Track Unresectable Gastric Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.